193 related articles for article (PubMed ID: 24643839)
21. [Adequate antibiotic therapy in intensive care units].
Engelmann L; Bellmann R
Med Klin Intensivmed Notfmed; 2014 Apr; 109(3):154-5. PubMed ID: 24652506
[No Abstract] [Full Text] [Related]
22. [Strategies to avoid antibiotic resistance].
Kees MG
Med Klin Intensivmed Notfmed; 2013 Mar; 108(2):125-30. PubMed ID: 23344520
[TBL] [Abstract][Full Text] [Related]
23. [Tarragona strategy--appropriate antibiotic therapy in the ICU].
Engelmann L; Schmitt DV
Med Klin Intensivmed Notfmed; 2014 Apr; 109(3):156-61. PubMed ID: 24652507
[TBL] [Abstract][Full Text] [Related]
24. [Personalised pharmacotherapy in intensive care unit patients].
Bellmann R
Med Klin Intensivmed Notfmed; 2017 May; 112(4):289-294. PubMed ID: 28466289
[TBL] [Abstract][Full Text] [Related]
25. Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock.
Taccone FS; Laterre PF; Dugernier T; Spapen H; Delattre I; Wittebole X; De Backer D; Layeux B; Wallemacq P; Vincent JL; Jacobs F
Crit Care; 2010; 14(4):R126. PubMed ID: 20594297
[TBL] [Abstract][Full Text] [Related]
26. In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistance.
Schentag JJ; Birmingham MC; Paladino JA; Carr JR; Hyatt JM; Forrest A; Zimmer GS; Adelman MH; Cumbo TJ
Semin Respir Infect; 1997 Dec; 12(4):278-93. PubMed ID: 9436955
[TBL] [Abstract][Full Text] [Related]
27. Pharmacodynamic principles of antimicrobial therapy in the prevention of resistance.
Burgess DS
Chest; 1999 Mar; 115(3 Suppl):19S-23S. PubMed ID: 10084455
[TBL] [Abstract][Full Text] [Related]
28. The DISPARITY-II study: delays to antibiotic administration in women with severe sepsis or septic shock.
Madsen TE; Napoli AM
Acad Emerg Med; 2014 Dec; 21(12):1499-502. PubMed ID: 25424151
[TBL] [Abstract][Full Text] [Related]
29. Recommended β-lactam regimens are inadequate in septic patients treated with continuous renal replacement therapy.
Seyler L; Cotton F; Taccone FS; De Backer D; Macours P; Vincent JL; Jacobs F
Crit Care; 2011; 15(3):R137. PubMed ID: 21649882
[TBL] [Abstract][Full Text] [Related]
30. Continuous infusion of antibiotics in critically ill patients.
Smuszkiewicz P; Szałek E; Tomczak H; Grześkowiak E
Curr Clin Pharmacol; 2013 Feb; 8(1):13-24. PubMed ID: 22946869
[TBL] [Abstract][Full Text] [Related]
31. Key Challenges in Providing Effective Antibiotic Therapy for Critically Ill Patients with Bacterial Sepsis and Septic Shock.
Landersdorfer CB; Nation RL
Clin Pharmacol Ther; 2021 Apr; 109(4):892-904. PubMed ID: 33570163
[TBL] [Abstract][Full Text] [Related]
32. Outcomes in severe sepsis and patients with septic shock: pathogen species and infection sites are not associated with mortality.
Zahar JR; Timsit JF; Garrouste-Orgeas M; Français A; Vesin A; Descorps-Declere A; Dubois Y; Souweine B; Haouache H; Goldgran-Toledano D; Allaouchiche B; Azoulay E; Adrie C
Crit Care Med; 2011 Aug; 39(8):1886-95. PubMed ID: 21516036
[TBL] [Abstract][Full Text] [Related]
33. Linezolid pharmacokinetic/pharmacodynamic profile in critically ill septic patients: intermittent versus continuous infusion.
Adembri C; Fallani S; Cassetta MI; Arrigucci S; Ottaviano A; Pecile P; Mazzei T; De Gaudio R; Novelli A
Int J Antimicrob Agents; 2008 Feb; 31(2):122-9. PubMed ID: 18055183
[TBL] [Abstract][Full Text] [Related]
34. Prolonged administration of β-lactam antibiotics - a comprehensive review and critical appraisal.
Osthoff M; Siegemund M; Balestra G; Abdul-Aziz MH; Roberts JA
Swiss Med Wkly; 2016; 146():w14368. PubMed ID: 27731492
[TBL] [Abstract][Full Text] [Related]
35. Delayed Administration of Antibiotics Beyond the First Hour of Recognition Is Associated with Increased Mortality Rates in Children with Sepsis/Severe Sepsis and Septic Shock.
Sankar J; Garg M; Ghimire JJ; Sankar MJ; Lodha R; Kabra SK
J Pediatr; 2021 Jun; 233():183-190.e3. PubMed ID: 33359300
[TBL] [Abstract][Full Text] [Related]
36. Antibiotic dose optimization in critically ill patients.
Cotta MO; Roberts JA; Lipman J
Med Intensiva; 2015 Dec; 39(9):563-72. PubMed ID: 26415688
[TBL] [Abstract][Full Text] [Related]
37. [Treatment of severe infections: should one always administer an aminoglycoside?].
Cometta A; Baumgartner JD
Schweiz Med Wochenschr Suppl; 1996; 76():28S-33S. PubMed ID: 8677416
[TBL] [Abstract][Full Text] [Related]
38. [First-line anti-infective treatment in sepsis].
Burgmann H
Med Klin Intensivmed Notfmed; 2014 Nov; 109(8):577-82. PubMed ID: 25344412
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of Meropenem Extended Versus Intermittent Infusion Dosing Protocol in Critically Ill Patients.
Ahmed N; Jen SP; Altshuler D; Papadopoulos J; Pham VP; Dubrovskaya Y
J Intensive Care Med; 2020 Aug; 35(8):763-771. PubMed ID: 29954243
[TBL] [Abstract][Full Text] [Related]
40. Population pharmacokinetics and Monte Carlo dosing simulations of meropenem during the early phase of severe sepsis and septic shock in critically ill patients in intensive care units.
Jaruratanasirikul S; Thengyai S; Wongpoowarak W; Wattanavijitkul T; Tangkitwanitjaroen K; Sukarnjanaset W; Jullangkoon M; Samaeng M
Antimicrob Agents Chemother; 2015; 59(6):2995-3001. PubMed ID: 25753628
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
